Zeltiq Aesthetics (ZLTQ) and Cogentix Medical (CGNT) Head to Head Survey
Zeltiq Aesthetics (NASDAQ: ZLTQ) and Cogentix Medical (NASDAQ:CGNT) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.
Earnings and Valuation
This table compares Zeltiq Aesthetics and Cogentix Medical’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|Cogentix Medical||$51.85 million||3.29||-$22.09 million||($0.41)||-6.83|
Institutional & Insider Ownership
12.8% of Cogentix Medical shares are owned by institutional investors. 15.6% of Zeltiq Aesthetics shares are owned by insiders. Comparatively, 62.7% of Cogentix Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This is a summary of current recommendations and price targets for Zeltiq Aesthetics and Cogentix Medical, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Zeltiq Aesthetics presently has a consensus target price of $56.83, suggesting a potential upside of 0.63%. Cogentix Medical has a consensus target price of $4.50, suggesting a potential upside of 60.71%. Given Cogentix Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Cogentix Medical is more favorable than Zeltiq Aesthetics.
This table compares Zeltiq Aesthetics and Cogentix Medical’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Cogentix Medical beats Zeltiq Aesthetics on 6 of the 10 factors compared between the two stocks.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.
About Cogentix Medical
Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.
Receive News & Ratings for Zeltiq Aesthetics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc and related companies with MarketBeat.com's FREE daily email newsletter.